GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Global Medical REIT Inc (NYSE:GMRE) » Definitions » EBIT

GMRE (Global Medical REIT) EBIT : $32.4 Mil (TTM As of Sep. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Global Medical REIT EBIT?

Global Medical REIT's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2024 was $10.6 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was $32.4 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Global Medical REIT's annualized ROC % for the quarter that ended in Sep. 2024 was 1.90%. Global Medical REIT's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 301.58%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Global Medical REIT's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 2.54%.


Global Medical REIT EBIT Historical Data

The historical data trend for Global Medical REIT's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Medical REIT EBIT Chart

Global Medical REIT Annual Data
Trend Aug14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.06 16.18 38.04 45.23 52.63

Global Medical REIT Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.00 7.54 9.20 5.04 10.63

Competitive Comparison of Global Medical REIT's EBIT

For the REIT - Healthcare Facilities subindustry, Global Medical REIT's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Global Medical REIT's EV-to-EBIT Distribution in the REITs Industry

For the REITs industry and Real Estate sector, Global Medical REIT's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Global Medical REIT's EV-to-EBIT falls into.



Global Medical REIT EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $32.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Global Medical REIT  (NYSE:GMRE) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Global Medical REIT's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

ROC % (Q: Sep. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Sep. 2024 ))/ count )
=34.86 * ( 1 - 0% )/( (1828.123 + 1843.794)/ 2 )
=34.86/1835.9585
=1.90 %

where

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Global Medical REIT's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=42.508/( ( (12.355 + max(-21.506, 0)) + (15.835 + max(-22.828, 0)) )/ 2 )
=42.508/( ( 12.355 + 15.835 )/ 2 )
=42.508/14.095
=301.58 %

where Working Capital is:

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(8.073 + 0 + 3.765) - (28.242 + 5.102 + 0)
=-21.506

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(8.122 + 0 + 3.76) - (29.884 + 4.826 + 0)
=-22.828

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Global Medical REIT's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2024 )
=32.406/1276.824
=2.54 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Global Medical REIT EBIT Related Terms

Thank you for viewing the detailed overview of Global Medical REIT's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Global Medical REIT Business Description

Traded in Other Exchanges
Address
7373 Wisconsin Avenue, Suite 800, Bethesda, MD, USA, 20814
Global Medical REIT Inc is a Maryland corporation engaged predominantly in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to physician groups and regional and national healthcare systems. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases.
Executives
Moore Roscoe M Jr director C/O HEMOBIOTECH, INC., 5001 SPRING VALLEY ROAD, SUITE 1040 WEST, DALLAS TX 75244
Henry Cole director 4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814
Jeffrey Busch director, officer: Chairman, President and CEO 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Lori Wittman director 191 NORTH WACKER DRIVE, SUITE 1200, CHICAGO IL 60606
Matthew Cypher director 4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814
Paula Crowley director 2 BETHESDA METRO CENTER, SUITE 440, BETHESDA MD 20814
Ronald Marston director 4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814
Robert J Kiernan officer: Chief Financial Officer 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Alfonzo Leon officer: Chief Investment Officer 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Danica Holley officer: Chief Operating Officer 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Jamie Allen Barber officer: Secretary and General Counsel 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Allen Webb officer: SVP 4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814
Huiqi Zhang director, 10 percent owner 40-44 WYNDHAM STREET, 24/F WYNDHAM PLACE, HONG KONG K3 00000
Notable Reward Ltd 10 percent owner VISTRA CORPORATE SERVICES CENTRE, WICKHAMS CAY II, ROAD TOWN TORTOLA D8 VG1110
Superior Glory Enterprises Ltd. 10 percent owner VISTRA CORPORATE SERVICES CENTRE, WICKHAMS CAY II, ROAD TOWN TORTOLA D8 VG1110